In conclusion, we discovered that GLTs relieved cognitive impairment and decreased NFT numbers in APP/PS1 transgenic AD model mice by inhibiting apoptosis and inactivating the ROCK signaling pathway. This evidence concerns the gene APP and Alzheimer disease.